- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT00814931
Examining the Effects of CXB722 in Neuroendocrine Stress Response in Healthy Males (CXB722-100)
A Phase 1, Multiple Dose, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Examining the Effects of CXB722 in Mitigating Neuroendocrine Stress Response in Healthy Males
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
Acute stress produces a cascade of physiological and psychological effects, including increased cardiovascular function, increases in circulating levels of stress hormones and neurotransmitter levels, and changes in mood and subjective state. The Trier Social Stress Test (TSST) is a standardized, well-validated procedure that was developed in order to provide a controlled method for exposing subjects to a stressor. The TSST consists of a public speaking and a mental arithmetic test performed in the context of a mock job interview.
A drug that could safely block or mitigate the stress response would have multiple applications in medicine, beyond treating anxiety, because stress is associated with many disease states, including cardiovascular disease. The drug being studied, CXB722, is thought to show promise in diminishing the physiologic and psychological effects of stress.
Studietyp
Inskrivning (Faktisk)
Fas
- Fas 1
Kontakter och platser
Studieorter
-
-
Florida
-
Tampa, Florida, Förenta staterna, 33612
- University of South Florida
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Male, 18 to 34 years of age, inclusive, at screening
- Able to read, understand and converse in English
- Able to read, understand, and provide written, dated informed consent
- Willing to refrain from the use of any concomitant medications (including over-the counter (OTC)) and nutritional/herbal supplements and comply with all study requirements
- Willing to submit to daily breathalyzer testing each day study medication is administered over the course of the study
- In good general health as ascertained by medical history, physical examination (PE) including measurement of vital signs, clinical laboratory evaluations, and 12-lead electrocardiogram (ECG)
Exclusion Criteria:
- Evidence on physical examination or laboratory findings of chronic liver or renal disease or other chronic physical disorders
- Evidence of cardiovascular disease on 12 lead ECG, vital signs or laboratory findings
- Significant anxiety as indicated by a score of 47 or higher on the "Trait" score of Spielberger State-Trait Anxiety Scale
- Family history (first degree relative) of hypertension or cardiovascular disease prior to age 40
- Evidence on physical or laboratory examination of endocrinopathies or immunopathies, including HIV
- BMI of 30 or greater, evidence of significant recent weight change or history of obesity
- History of any psychiatric disorder, or evidence of such a disorder based on a psychiatric evaluation which includes the Structured Clinical Interview for DSM-IV-TR (SCID)
- History of any physical condition which, in the investigator's opinion, might put the participant at risk or interfere with the interpretation of study results
- Use of any prescription or over-the-counter (OTC) medications (including herbal remedies) within 14 days of study randomization
- Use of tobacco products or any nicotine-containing products (e.g., gum, patch) within the past 6 months (prior to screening)
- Positive screening urine test for nicotine or drugs of abuse: cannabinoids, cocaine, amphetamines, barbiturates, opiates, benzodiazepines, or alcohol in the blood
- Unwillingness to agree to avoid strenuous activity over the course of the study
- Poor likelihood, in the investigator's judgment, of full cooperation during the study and/or poor compliance is anticipated
- Previously screened for this trial
- Consumes more than four cups of coffee daily
- Deviates from normal nocturnal sleeping patterns
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Trippel
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
---|---|
Placebo-jämförare: 2
|
matching oral liquid suspension placebo twice a day for 8 days
|
Experimentell: 1
Behandlingsgrupp
|
900 mg CXB722 oral liquid suspension twice a day for 8 days
Andra namn:
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Tidsram |
---|---|
Plasma cortisol and salivary cortisol levels
Tidsram: Screening and Study Day 8
|
Screening and Study Day 8
|
Sekundära resultatmått
Resultatmått |
Tidsram |
---|---|
Plasma ACTH
Tidsram: Screening and Study Day 8
|
Screening and Study Day 8
|
Plasma epinephrine and norepinephrine
Tidsram: Screening and Study Day 8
|
Screening and Study Day 8
|
Profile of Mood States (POMS) Tension-Anxiety
Tidsram: Screening and Study Day 8
|
Screening and Study Day 8
|
Fatigue-Inertia, and Vigor-Activity factor scores
Tidsram: Screening and Study Day 8
|
Screening and Study Day 8
|
"State" score on the Spielberger State-Trait Anxiety Scale (SSTAS)
Tidsram: Screening and Study Day 8
|
Screening and Study Day 8
|
Seven Visual Analog Scales (VAS)
Tidsram: Screening and Study Day 8
|
Screening and Study Day 8
|
HR, and systolic and diastolic BP
Tidsram: Screening and Study Day 8
|
Screening and Study Day 8
|
Samarbetspartners och utredare
Sponsor
Utredare
- Huvudutredare: Carlos Santana, MD, USF Physicians Group, Associate Professor, Director of Adult Outpatient Services, Department of Psychiatry and Behavioral Medicine
Publikationer och användbara länkar
Allmänna publikationer
- Kirschbaum C, Strasburger CJ, Langkrar J. Attenuated cortisol response to psychological stress but not to CRH or ergometry in young habitual smokers. Pharmacol Biochem Behav. 1993 Mar;44(3):527-31. doi: 10.1016/0091-3057(93)90162-m.
- Kirschbaum C, Pirke KM, Hellhammer DH. The 'Trier Social Stress Test'--a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology. 1993;28(1-2):76-81. doi: 10.1159/000119004.
Studieavstämningsdatum
Studera stora datum
Studiestart
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Andra studie-ID-nummer
- AG0114
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Påfrestning
-
Massachusetts General HospitalAvslutadPåfrestning | Känslomässig stress | Psykologisk stress | Social stress | LivsstressFörenta staterna
-
Holly RisdonBPAi; American Institute of StressHar inte rekryterat ännu
-
Mälardalen UniversityAvslutadHälsobeteende | Psykologisk stress | Occupation-Related Stress DisorderSverige
-
The Touro College and University SystemAvslutadStress, psykologisk | Stress, Fysiologisk | Stress, jobb | Student utbrändhetFörenta staterna
-
Oregon Health and Science UniversityAvslutadPsykologisk stress | Fysiologisk stress
-
Philipps University Marburg Medical CenterAvslutadPsykologisk stress | Fysiologisk stressTyskland
-
Claude Bernard UniversityAvslutadStress, psykologisk | Stress, Fysiologisk | Tenta stressFrankrike
-
Northwestern UniversityHarvard UniversityAktiv, inte rekryterandeStress, psykologisk | Stress, känslomässigt | Stress, FysiologiskFörenta staterna
-
University of Southern DenmarkHeadspace HealthAvslutadPsykologisk stress | Fysiologisk stressDanmark
-
National Taiwan University HospitalTaipei City HospitalOkändPsykologisk stress | Fysiologisk stressTaiwan